National Security Group I... (NSEC)
NASDAQ: NSEC
· Real-Time Price · USD
16.36
0.02 (0.15%)
At close: Jun 30, 2022, 10:00 PM
National Security Revenue Breakdown
Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Life Insurance Product Line Revenue | 2.31M | 2.08M | 2.32M | 2.59M | 2.42M | 2.46M | 3.2M | 2.62M | 1.83M | 2.87M | 2.45M | 2.46M | 2.47M | 3.31M | 2.39M | 1.95M | 2.09M | 1.75M | 2.09M | 2.13M | 2.23M | 1.94M | 2.41M | 2.2M | 2.09M | 1.96M | 2.23M | 2.18M | 2.16M | 1.94M | 2.21M | 2.45M | 2.17M | 1.93M | 2.29M |
Life Insurance Product Line Revenue Growth | +11.14% | -10.30% | -10.42% | +7.11% | -1.71% | -23.05% | +22.29% | +43.13% | -36.43% | +17.45% | -0.61% | -0.40% | -25.20% | +38.34% | +22.32% | -6.73% | +19.38% | -16.16% | -1.60% | -4.75% | +15.35% | -19.58% | +9.51% | +4.97% | +6.73% | -11.98% | +2.25% | +0.83% | +11.16% | -11.96% | -9.73% | +12.93% | +12.00% | -15.55% | n/a |
Product and Service, Other Revenue | 240K | 274K | 297K | 308K | 258K | 14.95M | 15.02M | 14.64M | 13.65M | 14.42M | 14.13M | 14.07M | 15.83M | 14.01M | 14.66M | 14.24M | 13.77M | 14.48M | 14.52M | 14.34M | 14.03M | 14.86M | 14.7M | 14.44M | 14.21M | 13.92M | 13.86M | 13.87M | 13.8M | 14.68M | 13.27M | 14.69M | 12.83M | 12.35M | 12.08M |
Product and Service, Other Revenue Growth | -12.41% | -7.74% | -3.57% | +19.38% | -98.27% | -0.44% | +2.58% | +7.21% | -5.33% | +2.07% | +0.41% | -11.09% | +12.99% | -4.46% | +3.00% | +3.40% | -4.90% | -0.30% | +1.27% | +2.20% | -5.57% | +1.10% | +1.81% | +1.61% | +2.04% | +0.49% | -0.09% | +0.49% | -5.99% | +10.63% | -9.67% | +14.50% | +3.87% | +2.24% | n/a |
Property, Liability and Casualty Insurance Product Line Revenue | 14.26M | 15.22M | 14.7M | 14.01M | 14.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Property, Liability and Casualty Insurance Product Line Revenue Growth | -6.29% | +3.52% | +4.97% | -1.47% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.12M | 2.81M | 1.98M | 2.57M | 2.3M | 3.1M | 2.31M | 2.49M | 1.39M | 2.72M | 2.23M | 2.42M | 2.33M | 1.76M | 2.4M | 2.67M | 2M | 2.27M | 5.2M | 4.49M | 4.58M | 4.76M | 4.64M | 4.85M | 4.84M | 4.99M | 4.26M | 4.7M | 4.72M |
Selling, General, and Administrative Revenue Growth | -24.54% | +41.60% | -22.72% | +11.37% | -25.65% | +34.04% | -7.26% | +78.84% | -48.83% | +22.37% | -7.86% | +3.60% | +32.20% | -26.62% | -9.90% | +33.20% | -11.84% | -56.33% | +15.88% | -1.94% | -3.90% | +2.63% | -4.25% | +0.25% | -3.05% | +17.09% | -9.34% | -0.34% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |